Holen Sie sich die Stockscreener-App
12.80
0.31%
-0.04
Handel nachbörslich:
12.81
0.010
+0.08%
Schlusskurs vom Vortag:
$12.84
Offen:
$12.74
24-Stunden-Volumen:
52,437
Relative Volume:
0.23
Marktkapitalisierung:
$184.61M
Einnahmen:
$6.39M
Nettoeinkommen (Verlust:
$-117.26M
KGV:
-1.0256
EPS:
-12.4807
Netto-Cashflow:
$-79.08M
1W Leistung:
-5.11%
1M Leistung:
+23.08%
6M Leistung:
-68.06%
1J Leistung:
-26.73%
1-Tages-Spanne:
$12.68
$13.13
1-Wochen-Bereich:
$12.68
$14.14
52-Wochen-Spanne:
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
Firmenname
Korro Bio Inc
Sektor
Branche
Telefon
617-468-1999
Adresse
60 FIRST STREET, CAMBRIDGE
Compare KRRO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
12.80 | 185.19M | 6.39M | -117.26M | -79.08M | -12.48 |
VRTX
Vertex Pharmaceuticals Inc
|
430.14 | 108.36B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
731.77 | 78.05B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
775.03 | 48.74B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
302.11 | 41.16B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
298.16 | 33.17B | 5.36B | 287.73M | 924.18M | 2.5229 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2026-02-17 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2026-01-29 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2026-01-29 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2026-01-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-01-28 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2026-01-28 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-11-13 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-08-14 | Eingeleitet | William Blair | Outperform |
| 2024-03-28 | Bestätigt | H.C. Wainwright | Buy |
| 2024-02-27 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-11-10 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
| 2021-01-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
| 2020-07-14 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Eingeleitet | Cowen | Outperform |
| 2019-10-28 | Eingeleitet | Goldman | Buy |
| 2019-10-28 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
Korro announces oversubscribed $85 million private placement - MSN
What Makes Korro Bio, Inc. (KRRO) a New Buy Stock - Yahoo Finance Australia
Korro Bio (KRRO) Moat Analysis | Q4 2025: Earnings Beat EstimatesExpert Momentum Signals - Cổng thông tin điện tử tỉnh Lào Cai
Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences - The Manila Times
Korro brings ammonia and liver disease data to 4 spring conferences - Stock Titan
[ARS] Korro Bio, Inc. SEC Filing - Stock Titan
Korro Bio (KRRO) outlines 2026 virtual meeting, director elections and pay vote - Stock Titan
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule - National Today
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Korro Bio reports inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - TradingView
New Korro Bio hire gets stock option for 15,000 shares under Nasdaq rule - Stock Titan
Block Trades: Does Korro Bio Inc have pricing powerWeekly Investment Summary & Reliable Breakout Forecasts - baoquankhu1.vn
Lynx1 Capital Management LP Increases Stake in Korro Bio Inc - GuruFocus
Ideas Watch: Is Korro Bio Inc stock a good pick for beginners2026 Institutional & Weekly High Conviction Trade Ideas - baoquankhu1.vn
KRRO|Korro Bio Inc|Price:13.460|Chg%:-0.45 - TradingKey
Analyst Upgrade: Is Korro Bio Inc stock overvalued or fairly priced2026 Short Interest & AI Driven Price Predictions - baoquankhu1.vn
Can Lithium Americas Corp stock outperform in a bear marketWeekly Stock Recap & Reliable Momentum Entry Alerts - baoquankhu1.vn
Is Korro Bio (KRRO) Stock Trending Up | Price at $14.83, Up 5.93%Debt Free Stocks - Cổng thông tin điện tử tỉnh Lào Cai
KRRO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
KRRO Receives Upgraded Analyst Rating and Price Target Boost fro - GuruFocus
Lynx1 Capital buys Korro Bio (KRRO) shares worth $5512 By Investing.com - Investing.com South Africa
Lynx1 Capital buys Korro Bio (KRRO) shares worth $5512 - Investing.com
Lynx1 and Weston Nichols report 1.54M shares in Korro Bio (NASDAQ: KRRO) - Stock Titan
Lynx1 fund tied to Weston Nichols adds Korro Bio (KRRO) position - Stock Titan
Fund linked to Korro Bio (KRRO) reports 1.54M shares on Form 3 - Stock Titan
Earnings Update: Can Korro Bio Inc be recession proof2026 Short Interest & Reliable Volume Spike Alerts - baoquankhu1.vn
KRRO Price Today: Korro Bio, Inc. Stock Price, Quote & Chart - MEXC Exchange
Investment Recap: Should you avoid Korro Bio Inc stock right now2026 Volume & Community Consensus Trade Signals - baoquankhu1.vn
Breakout Watch: Will Korro Bio Inc benefit from green energy policiesAnalyst Upgrade & AI Forecast Swing Trade Picks - baoquankhu1.vn
JPMorgan Chase & Co. Buys 196,079 Shares of Korro Bio, Inc. $KRRO - MarketBeat
Korro Bio, Inc. (NASDAQ:KRRO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Aug Shorts: What is the next catalyst for Korro Bio Inc2026 Historical Comparison & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Trading Recap: Can Korro Bio Inc disrupt its industry2026 Support & Resistance & Risk Managed Investment Signals - baoquankhu1.vn
Vanguard (KRRO) reports zero beneficial ownership after realignment - Stock Titan
Korro Bio stock gains after tough 2025new drug candidate, analyst upgrades boost outlook - MSN
[EFFECT] Korro Bio, Inc. SEC Filing - Stock Titan
Form 424B5 Korro Bio Inc For: 20 March By Investing.com - Investing.com Canada
Aug Decliners: What is the next catalyst for Korro Bio IncPortfolio Return Report & Verified Swing Trading Watchlists - baoquankhu1.vn
Form 424B5 Korro Bio Inc For: 20 March - Investing.com
Korro Bio (NASDAQ: KRRO) registers 7.65M shares for resale after $85M private placement - Stock Titan
Energy Moves: Will Korro Bio Inc stock hit new highs in YEAR2026 Geopolitical Influence & High Return Trade Opportunity Guides - baoquankhu1.vn
Korro Bio, Inc. (KRRO) reports Q4 loss, lags revenue estimates - MSN
Venrock entities cap ownership at 9.99% in Korro Bio (KRRO) Schedule 13G - Stock Titan
Korro Bio raises $85 million in private equity financing By Investing.com - Investing.com Nigeria
KRRO SEC FilingsKorro Bio, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Korro Bio Stock Gains After Tough 2025New Drug Candidate, Analyst Upgrades Boost Outlook - Sahm
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
RBC Capital Keeps Their Hold Rating on Korro Bio (KRRO) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Solid Biosciences (SLDB), Korro Bio (KRRO) and Pharming Group (PHAR) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Sagimet Biosciences, Inc. Class A (SGMT) and Bristol-Myers Squibb (BMY) - The Globe and Mail
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):